These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38403164)

  • 21. Excess of nerve growth factor in the ovary causes a polycystic ovary-like syndrome in mice, which closely resembles both reproductive and metabolic aspects of the human syndrome.
    Wilson JL; Chen W; Dissen GA; Ojeda SR; Cowley MA; Garcia-Rudaz C; Enriori PJ
    Endocrinology; 2014 Nov; 155(11):4494-506. PubMed ID: 25211588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide DNA methylation and gene expression patterns provide insight into polycystic ovary syndrome development.
    Wang XX; Wei JZ; Jiao J; Jiang SY; Yu DH; Li D
    Oncotarget; 2014 Aug; 5(16):6603-10. PubMed ID: 25051372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative analysis of follistatin (FST) promoter methylation in peripheral blood of patients with polycystic ovary syndrome.
    Sang Q; Zhang S; Zou S; Wang H; Feng R; Li Q; Jin L; He L; Xing Q; Wang L
    Reprod Biomed Online; 2013 Feb; 26(2):157-63. PubMed ID: 23265961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of epigenetic interactions between microRNA and DNA methylation associated with polycystic ovarian syndrome.
    Mao Z; Li T; Zhao H; Qin Y; Wang X; Kang Y
    J Hum Genet; 2021 Feb; 66(2):123-137. PubMed ID: 32759991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypomethylation of the LH/choriogonadotropin receptor promoter region is a potential mechanism underlying susceptibility to polycystic ovary syndrome.
    Wang P; Zhao H; Li T; Zhang W; Wu K; Li M; Bian Y; Liu H; Ning Y; Li G; Chen ZJ
    Endocrinology; 2014 Apr; 155(4):1445-52. PubMed ID: 24527662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
    Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
    Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between single nucleotide polymorphisms, TGF-β1 promoter methylation, and polycystic ovary syndrome.
    Gao M; Liu X; Gu H; Xu H; Zhong W; Wei X; Zhong X
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):5. PubMed ID: 38166771
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide screen of ovary-specific DNA methylation in polycystic ovary syndrome.
    Yu YY; Sun CX; Liu YK; Li Y; Wang L; Zhang W
    Fertil Steril; 2015 Jul; 104(1):145-53.e6. PubMed ID: 25956362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic/circadian clocks and PCOS.
    Vatier C; Christin-Maitre S
    Hum Reprod; 2024 Jun; 39(6):1167-1175. PubMed ID: 38600622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Derailed peripheral circadian genes in polycystic ovary syndrome patients alters peripheral conversion of androgens synthesis.
    Johnson BS; Krishna MB; Padmanabhan RA; Pillai SM; Jayakrishnan K; Laloraya M
    Hum Reprod; 2022 Jul; 37(8):1835-1855. PubMed ID: 35728080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated analysis of DNA methylation and transcriptome profiling of polycystic ovary syndrome.
    Liu L; He D; Wang Y; Sheng M
    Mol Med Rep; 2020 May; 21(5):2138-2150. PubMed ID: 32323770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome.
    Jiang LL; Xie JK; Cui JQ; Wei D; Yin BL; Zhang YN; Chen YH; Han X; Wang Q; Zhang CL
    Medicine (Baltimore); 2017 Jan; 96(2):e5768. PubMed ID: 28079802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic and Transcriptional Alterations in Human Adipose Tissue of Polycystic Ovary Syndrome.
    Kokosar M; Benrick A; Perfilyev A; Fornes R; Nilsson E; Maliqueo M; Behre CJ; Sazonova A; Ohlsson C; Ling C; Stener-Victorin E
    Sci Rep; 2016 Mar; 6():22883. PubMed ID: 26975253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic Reprogramming of Immune Cells in Women With PCOS Impact Genes Controlling Reproductive Function.
    Hiam D; Simar D; Laker R; Altıntaş A; Gibson-Helm M; Fletcher E; Moreno-Asso A; Trewin AJ; Barres R; Stepto NK
    J Clin Endocrinol Metab; 2019 Dec; 104(12):6155-6170. PubMed ID: 31390009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulated Ribosomal Pathway Impairs Follicle Development in a Polycystic Ovary Syndrome Mouse Model: Differential Gene Expression Analysis of Oocytes.
    Nakanishi N; Osuka S; Kono T; Kobayashi H; Ikeda S; Bayasula B; Sonehara R; Murakami M; Yoshita S; Miyake N; Muraoka A; Kasahara Y; Murase T; Nakamura T; Goto M; Iwase A; Kajiyama H
    Reprod Sci; 2023 Apr; 30(4):1306-1315. PubMed ID: 36194357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addressing the role of 11β-hydroxysteroid dehydrogenase type 1 in the development of polycystic ovary syndrome and the putative therapeutic effects of its selective inhibition in a preclinical model.
    Li X; Hu S; Zhu Q; Yao G; Yao J; Li J; Wang Y; Ding Y; Qi J; Xu R; Zhao H; Zhu Z; Du Y; Sun K; Sun Y
    Metabolism; 2021 Jun; 119():154749. PubMed ID: 33722534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic regulation of an adverse metabolic phenotype in polycystic ovary syndrome: the impact of the leukocyte methylation of PPARGC1A promoter.
    Zhao H; Zhao Y; Ren Y; Li M; Li T; Li R; Yu Y; Qiao J
    Fertil Steril; 2017 Feb; 107(2):467-474.e5. PubMed ID: 27889100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome.
    Shukla P; Mukherjee S
    Mitochondrion; 2020 May; 52():24-39. PubMed ID: 32081727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycystic Ovary Syndrome: the Epigenetics Behind the Disease.
    Eiras MC; Pinheiro DP; Romcy KAM; Ferriani RA; Reis RMD; Furtado CLM
    Reprod Sci; 2022 Mar; 29(3):680-694. PubMed ID: 33826098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity.
    Jones MR; Brower MA; Xu N; Cui J; Mengesha E; Chen YD; Taylor KD; Azziz R; Goodarzi MO
    PLoS Genet; 2015 Aug; 11(8):e1005455. PubMed ID: 26305227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.